Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Moticont releases LVCM-051-127-02 and LVCM-051-127-03 DC motors October 2, 2019 India’s electric vehicles push likely to benefit Chinese car makers May 24, 2017 Microchip Technology announces MCP331x1(D)-xx family of SAR ADCs with companion MCP6D11 differential amplifier March 7, 2019
Microchip Technology announces MCP331x1(D)-xx family of SAR ADCs with companion MCP6D11 differential amplifier March 7, 2019